期刊
FRONTIERS IN PHARMACOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.00912
关键词
SARS-CoV-2; pandemic; COVID-19; drug screening; RGD; integrin
资金
- National Natural Science Foundation of China [31701114, 21672266]
- Guangdong Basic and Applied Basic Research Foundation [2019A050510019]
- Science and Technology Planning Project of Guangdong Province [2017B030314030]
- Guangzhou Science and Technology Planning Program [202002020051]
- National Engineering Research Center for New Drug and Druggability Evaluation, Seed Program of Guangdong Province [2017B090903004]